9 December 2026

Invest Live: IPOs & Market Introductions 2026 – Company presentation (On-line)

On December 9, newly listed companies will come together for an event focusing on this year’s IPOs and market introductions. Read more here

25 November 2026

Økonomisk Ugebrev: Investor conference – Company presentation, Copenhagen (DANISH)

For more information and to sign-up for the event, click on the link

12 November 2026

Aktiespararna Life Science Evening – Company presentation (online event)

Read more here link

9 November 2026

Finwire: Interview with CEO Anders Kronborg

Listen to Anders Kronborg speak about the Phase 2b study timeline and next value triggers for RTP-026 as a potential first-in-class cardioprotectant, as the company prepares for public listing in early December.

29 October 2026

KapitalForum 2026 Investor event, Copenhagen – Company presentation (DANISH)

See CFO Hanne Vissing Leth present business focus, including RTP-026 as a potential first-in-class therapy for patients after an acute heart attack, and the investment case ahead of the company’s planned public listing on Spotlight

22 September 2026

BioStock investor event: Investing in Life Science – From Seed to Success, Stockholm – Company presentation

See CEO Anders Kronborg present the company’s unique approach to better treatment of hyperinflammatory diseases and in particular the outlook and value potential for RTP-026 in patients with an acute heart attack

21 September 2026

BioStock: Management interview

Listen to our CEO and CFO speak about the Phase 2a results for RTP-026 in acute heart attack and the road to Phase 2b.

Listen here